The predictive value of peripheral blood-derived inflammatory markers SII and SIRI for in-hospital adverse cardiovascular events in patients with acute myocardial infarction
Author:
Affiliation:

Cardiovascular Center of Suining Central Hospital, Suning, Sichuan 629000, China)

Clc Number:

R5

  • Article
  • | |
  • Metrics
  • |
  • Reference [28]
  • | | | |
  • Comments
    Abstract:

    Aim To investigate the relationship between systemic inflammatory immune index (SII) and systemic inflammatory response index (SIRI) and the risk of in-hospital major adverse cardiovascular events (MACE) in patients with acute myocardial infarction (AMI). Methods Retrospective analysis was conducted on AMI patients admitted to the Second Cardiovascular Disease Area of Suining Central Hospital from February 2021 to May 2022. Based on inclusion and exclusion criteria, 246 patients were finally enrolled. According to whether MACE occurred during hospitalization, they were divided into event group and non-event group, and baseline data of the two groups were compared.All variables except SII and SIRI were included in a univariate-multivariate Logistic regression analysis to screen factors affecting the risk of MACE, and were used as significant covariates for adjustment to evaluate the relationship between SII and SIRI and the risk of MACE respectively. Results The results of multivariate Logistic regression analysis showed that emergency PCI, left ventricular ejection fraction, albumin level and age were significant factors affecting the risk of in-hospital MACE in AMI patients (OR=0.2,5%CI:0.194~0.960, P=0.038; OR=0.0,5%CI:0.890~0.969, P=0.001; OR=0.0,5%CI:0.621~0.845, P<0.001; OR=1.3,5%CI:1.070~1.228, P<0.001), and a basic model was established based on this. After adjusting for the significant covariates, SII and SIRI were both independent risk factors for in-hospital MACE (OR=1.4,5%CI:1.001~1.008, P=0.002; OR=4.7,5%CI:2.597~8.142, P<0.001). The areas under the curves of SII and SIRI were 0.658 and 0.785, respectively, and the optimal cutoff values were 434.83 and 1.03. Restricted cubic spline analysis showed that SII (Nonlinear P=0.639) and SIRI (Nonlinear P=0.683) were linearly related to the risk of MACE after adjusting significant covariates. Threshold effect analysis showed that when SIRI>0.93, the risk of MACE began to increase. Conclusion Elevated levels of SII and SIRI are independent risk predictors for the occurrence of in-hospital MACE in AMI patients.

    Reference
    [1] World Health Organization.Cardiovascular diseases(CVDs)[EB/OL].(2021-06-11).https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds).
    [2] ARNETT D K, BLUMENTHAL R S, ALBERT M A, et al.2019 ACC/AHA guideline on the primary prevention of cardiovascular disease:a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.Circulation, 9,0(11):e596-e646.
    [3] IBANEZ B, JAMES S, AGEWALL S, et al.2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation:the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).Eur Heart J, 8,9(2):119-177.
    [4] XU H Y, YANG Y J, WANG C S, et al.Association of hospital-level differences in care with outcomes among patients with acute ST-segment elevation myocardial infarction in China.JAMA Netw Open, 0,3(10):e2021677.
    [5] HARRINGTON J, JONES W S, UDELL J A, et al.Acute decompensated heart failure in the setting of acute coronary syndrome.JACC Heart Fail, 2,0(6):404-414.
    [6] HENRY T D, TOMEYⅠM, TAMIS-HOLLAND J E, et al.Invasive management of acute myocardial infarction complicated by cardiogenic shock:a scientific statement from the American Heart Association.Circulation, 1,3(15):e815-e829.
    [7] SAMSKY M D, MORROW D A, PROUDFOOT A G, et al.Cardiogenic shock after acute myocardial infarction:a review.JAMA, 1,6(18):1840-1850.
    [8] SOEHNLEIN O, LIBBY P.Targeting inflammation in atherosclerosis:from experimental insights to the clinic.Nat Rev Drug Discov, 1,0(8):589-610.
    [9] 李丹丹, 梅俊, 周庆兵, 等.固有免疫介导的炎症反应在动脉粥样硬化发病机制中的研究进展.中国动脉硬化杂志, 2,0(1):71-76.LI D D, MEI J, ZHOU Q B, et al.Research progress of innate immune mediated inflammatory response in pathogenesis of atherosclerosis.Chin J Arterioscler, 2,0(1):71-76.
    [10] LIU C Y, ZHOU Y, CHEN T, et al.AMPK/SIRT1 pathway is involved in arctigenin-mediated protective effects against myocardial ischemia-reperfusion injury.Front Pharmacol, 1,1:616813.
    [11] DZIEDZIC E A, GASIOR J S, TUZIMEK A, et al.Investigation of the associations of novel inflammatory biomarkers-systemic inflammatory index (SII)and systemic inflammatory response index (SIRI)-with the severity of coronary artery disease and acute coronary syndrome occurrence.Int J Mol Sci, 2,3(17):9553.
    [12] 中华医学会心血管病学分会, 中华心血管病杂志编辑委员会.急性ST段抬高型心肌梗死诊断和治疗指南(2019).中华心血管病杂志, 9,7(10):766-783.The Cardiovascular Branch of the Chinese Medical Association, Editorial Committee of Chinese Journal of Cardiovascular Disease.2019 Chinese Society of Cardiology (CSC) guidelines for the diagnosis and management of patients with ST-segment elevation myocardial infarction.Chin J Cardiol, 9,7(10):766-783.
    [13] FEI X H, CEN X J, ZHAO R C, et al.PRMT5 knockdown enhances cell viability and suppresses cell apoptosis, oxidative stress, inflammation and endothelial dysfunction in ox-LDL-induced vascular endothelial cells via interacting with PDCD4.Int Immunopharmacol, 3,2:110529.
    [14] JI Z J, LIU G R, GUO J Q, et al.The neutrophil-to-lymphocyte ratio is an important indicator predicting in-hospital death in AMI patients.Front Cardiovasc Med, 1,8:706852.
    [15] NORDING H, BARON L, LANGER H F.Platelets as therapeutic targets to prevent atherosclerosis.Atherosclerosis, 0,7:97-108.
    [16] HAN K N, SHI D M, YANG L X, et al.Prognostic value of systemic inflammatory response index in patients with acute coronary syndrome undergoing percutaneous coronary intervention.Ann Med, 2,4(1):1667-1677.
    [17] URBANOWICZ T, OLASIN'SKA-WIS'NIEWSKA A, MICHALAK M, et al.The prognostic significance of neutrophil to lymphocyte ratio (NLR), monocyte to lymphocyte ratio (MLR) and platelet to lymphocyte ratio (PLR) on long-term survival in off-pump coronary artery bypass grafting (OPCAB) procedures.Biology (Basel), 1,1(1):34.
    [18] GERMANO D B, OLIVEIRA S B, BACHI A L L, et al.Monocyte chemokine receptors as therapeutic targets in cardiovascular diseases.Immunol Lett, 3,6-257:1-8.
    [19] BUONO C, BINDER C J, STAVRAKIS G, et al.T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses.Proc Natl Acad Sci U S A, 5,2(5):1596-1601.
    [20] AMMIRATI E, MORONI F, MAGNONI M, et al.The role of T and B cells in human atherosclerosis and atherothrombosis.Clin Exp Immunol, 5,9(2):173-187.
    [21] JIN Z Q, WU Q, CHEN S H, et al.The associations of two novel inflammation indexes, SII and SIRI with the risks for cardiovascular diseases and all-cause mortality:a ten-year follow-up study in 85 154 individuals.J Inflamm Res, 1,4:131-140.
    [22] QI Q, ZHUANG L P, SHEN Y H, et al.A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy.Cancer, 6,2(14):2158-2167.
    [23] XU Y Y, HE H J, ZANG Y S, et al.Systemic inflammation response index (SIRI) as a novel biomarker in patients with rheumatoid arthritis:a multi-center retrospective study.Clin Rheumatol, 2,1(7):1989-2000.
    [24] YANG Y L, WU C H, HSU P F, et al.Systemic immune-inflammation index (SII) predicted clinical outcome in patients with coronary artery disease.Eur J Clin Invest, 0,0(5):e13230.
    [25] ADATIA K, FARAG M F, GUE Y X, et al.Relationship of platelet reactivity and inflammatory markers to recurrent adverse events in patients with ST-elevation myocardial infarction.Thromb Haemost, 9,9(11):1785-1794.
    [26] SHETELIG C, LIMALANATHAN S, HOFFMANN P, et al.Association of IL-8 with infarct size and clinical outcomes in patients with STEMI.J Am Coll Cardiol, 8,2(2):187-198.
    [27] BROCH K, ANSTENSRUD A K, WOXHOLT S, et al.Randomized trial of interleukin-6 receptor inhibition in patients with acute ST-segment elevation myocardial infarction.J Am Coll Cardiol, 1,7(15):1845-1855.
    [28] MATTER M A, PANENI F, LIBBY P, et al.Inflammation in acute myocardial infarction:the good, the bad and the ugly.Eur Heart J, 4,5(2):89-103.
    Related
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

TANG Kai, LIU Lei, TAN Zhen, ZHUANG Gang, DENG Xuejun, ZHOU Shiheng. The predictive value of peripheral blood-derived inflammatory markers SII and SIRI for in-hospital adverse cardiovascular events in patients with acute myocardial infarction[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2024,32(7):606-612.

Copy
Share
Article Metrics
  • Abstract:337
  • PDF: 3158
  • HTML: 0
  • Cited by: 0
History
  • Received:December 19,2023
  • Revised:April 03,2024
  • Online: July 05,2024
Article QR Code